New research project: ICEBIO

Dr. Brill + Partner prepares risk assessment

ICEBIO is a PhD network that will train the next generation of experts in glacier microbiology and biogeochemistry.

In all 11 doctoral candidates will work together to advance our understanding of microbial and biogeochemical processes in a range of glacial ecosystems, the exchanges between them and the surrounding ecosystems. (Graphics © ICEBIO)

ICEBIO will provide a database of the functional diversity and potential of the glacier biome, which will not only greatly improve our understanding of a threatened biome, but also demonstrate the potential for exploiting economic and ecological services.

Dr. Brill + Partner GmbH will, among other things, provide a risk assessment regarding pathogenic organisms from the glacier biome, including the inclusion of bacteria, fungi, and viruses.

Further Information: https://www.icebio.eu/pages/project/index.html

The ICEBIO Doctoral Network is supported by a grant from the European Commission’s MSCA Doctoral Network program under project number 101072761

More News

To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …
Evotec has started the search for a permanent solution for the position of CEO.

Evotec announces CEO transition

Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...

Read more …
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …